This fragment binds TGF-β receptors and elicits TGF-β-Smad2/3 signaling pathways, which drive EMT, migration and invasion of lung cancer cells as well as extracellular matrix deposition and angiogenesis [48]. This evidence concerns the gene TGFB1 and lung carcinoma.